Exchange Traded Concepts, LLC Exelixis, Inc. Transaction History

Exchange Traded Concepts, LLC

$7.62 Billion
Q2 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 131,950 shares of EXEL stock, worth $5.82 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

131,950

Previous 28,486 363.21%

Holding current value

$5.82 Million

Previous $1.05 Million 453.38%

% of portfolio

0.08%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	BUY	$34.13 - $46.26 $3.53 Million - $4.79 Million	103,464 Added 363.21%	131,950 $5.82 Million
Q1 2025 Apr 17, 2025	SELL	$32.38 - $39.16 $2.02 Million - $2.44 Million	-62,372 Reduced 68.65%	28,486 $1.05 Million
Q4 2024 Jan 21, 2025	BUY	$25.39 - $36.46 $1.29 Million - $1.85 Million	50,640 Added 125.91%	90,858 $3.03 Million
Q3 2024 Oct 10, 2024	SELL	$21.96 - $27.6 $55,449 - $69,690	-2,525 Reduced 5.91%	40,218 $1.04 Million
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $21,763 - $25,391	-1,070 Reduced 2.44%	42,743 $960,000
Q1 2024 Apr 15, 2024	SELL	$20.17 - $23.93 $1.5 Million - $1.78 Million	-74,546 Reduced 62.98%	43,813 $1.04 Million
Q4 2023 Jan 05, 2024	BUY	$19.25 - $24.13 $1.62 Million - $2.03 Million	83,999 Added 244.47%	118,359 $2.84 Million
Q3 2023 Oct 18, 2023	SELL	$19.04 - $22.74 $189,086 - $225,830	-9,931 Reduced 22.42%	34,360 $750,000
Q2 2023 Jul 20, 2023	BUY	$18.17 - $20.48 $119,867 - $135,106	6,597 Added 17.5%	44,291 $846,000
Q1 2023 Apr 12, 2023	BUY	$16.3 - $19.41 $63,292 - $75,369	3,883 Added 11.48%	37,694 $731,000
Q4 2022 Jan 17, 2023	BUY	$14.96 - $17.39 $8,437 - $9,807	564 Added 1.7%	33,811 $542,000
Q3 2022 Oct 07, 2022	BUY	$15.68 - $22.27 $521,312 - $740,410	33,247 New	33,247 $521,000
Q3 2021 Oct 18, 2021	SELL	$16.3 - $21.14 $387,092 - $502,032	-23,748 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$17.95 - $25.56 $66,450 - $94,623	3,702 Added 18.47%	23,748 $433,000
Q1 2021 Apr 20, 2021	BUY	$20.53 - $25.22 $105,832 - $130,009	5,155 Added 34.62%	20,046 $453,000
Q4 2020 Jan 19, 2021	BUY	$18.39 - $24.8 $12,468 - $16,814	678 Added 4.77%	14,891 $299,000
Q3 2020 Oct 30, 2020	BUY	$20.67 - $26.94 $45,908 - $59,833	2,221 Added 18.52%	14,213 $348,000
Q2 2020 Jul 15, 2020	BUY	$16.46 - $27.42 $197,388 - $328,820	11,992 New	11,992 $285,000

Others Institutions Holding EXEL

# of Institutions

624

Shares Held

257M

Call Options Held

1.57M

Put Options Held

730K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $14.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Exelixis, Inc. Transaction History